Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104593
Filing Date
2025-08-07
Accepted
2025-08-07 08:04:35
Documents
71
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sln-20250630.htm   iXBRL 10-Q 2001737
2 EX-3.1 sln-ex3_1.htm EX-3.1 854362
3 EX-31.1 sln-ex31_1.htm EX-31.1 15759
4 EX-31.2 sln-ex31_2.htm EX-31.2 15623
5 EX-32.1 sln-ex32_1.htm EX-32.1 10138
6 GRAPHIC img239821805_0.jpg GRAPHIC 6087
  Complete submission text file 0000950170-25-104593.txt   8754278

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sln-20250630.xsd EX-101.SCH 1174102
73 EXTRACTED XBRL INSTANCE DOCUMENT sln-20250630_htm.xml XML 1305846
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 10-Q | Act: 34 | File No.: 001-39487 | Film No.: 251191729
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)